Soleno Therapeutics (SLNO)

• Market cap: $2.56B
• 1 day: 9.55%
• 5 days: -29.85%
• 1 month: -23.2%
• 3 months: -39.4%
• 6 months: -36.11%
• Year to date: 4.35%
• 1 year: -16.48%
• 5 years: 59.8%
• 10 years: -65.25%
• Sector: Healthcare
• Industry: Biotechnology

About: Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Employees: 133